Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg

The Lancet

Volumn 346, Issue 8973, 1995, Pages 459-461

  Kock, H J ^a   Schmit Neuerburg, K P ^a   Hanke, J ^a   Rudofsky, G ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; MONOEMBOLEX;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; ECZEMA; FEMALE; HEMATOMA; HUMAN; IMMOBILIZATION; INCIDENCE; LEG FRACTURE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PLASTER CAST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029091031     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)91320-3     Document Type: Article

References (22)

1. European Consensus Statement—Prevention of Venous Thromboembolism
2. Treatment for acute tears of the lateral ligaments of the ankle
3. Diagnosis and treatment of venous thromboembolism
4. A multiple testing procedure for clinical trials
5. Thrombosis following leg injuries
6. Incidence of thrombosis in patients with tibial fractures
7. Traumatische Thrombosen im tiefen Venensystem bei frischen Unterschenkelfrakturen
8. Thromboseprophylaxe bei ambulanten Patienten mit Verletzungen der unteren Extremität
9. Low molecular weight heparin for the prevention of thromboembolism in outpatients immobilized by plaster case
10. Ambulante Thromboseprophylaxe mit niedermolekularem Herparin bei Gipsimmobilisation der unteren Extremität
11. Thromboembolieprophylaxe in der Allgemeinchirurgie
12. Thromboembolieprophylaxe in der Unfallchirurgie und Orthopädie
13. Empfehlungen zur Thromboseprophylaxe bei ambulanten Patienten
14. Ambulante Thromboembolieprophylaxe mit niedermolekularem Heparin
15. Ambulante Thromboembolieprophylaxe in der Traumatologie durch Selbstinjektion von Heparin
16. Can low molecular weight hepanns and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
17. Pathogenesis of venous thrombosis
18. The origin of deep vein thrombosis: a venographic study
19. Prevention of venous thromboembolism